Overall Status

Active, not recruiting (1)

Not yet recruiting (1)

Recruiting (1)

Phase

n/a (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Children's Oncology Group (1)

Fred Hutchinson Cancer Center (1)

National Cancer Institute (NCI) (1)

Collaborator

National Cancer Institute (NCI) (2)

Intervention

best practice (1)

cabozantinib (1)

cabozantinib s-malate (1)

dual x-ray absorptiometry (1)

internet-based intervention (1)

pharmacological study (1)

questionnaire administration (1)

tegavivint (1)

x-ray imaging (1)

Study Documents

Intervention Type

drug (2)

other (2)

procedure (1)

Funder Type

Other (2)

NIH (1)

Study Type

Interventional (3)

refractory hepatocellular carcinoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)

Recruiting

Colorectal Carcinoma
+21 more

Dual X-ray Absorptiometry
+2 more

Birmingham, Alabama
+18 more

Jan 30, 2023

Adrenal Cortex Carcinoma, Alveolar Soft Part Sarcoma, CNS Tumor Trial in United States (Cabozantinib, Cabozantinib S-malate,

Active, not recruiting

Adrenal Cortex Carcinoma
+39 more

Cabozantinib
+2 more

Birmingham, Alabama
+142 more

May 24, 2022

Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma

Not yet recruiting

Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
+45 more

Internet-Based Intervention
+2 more

Manhasset, New York
+3 more

Mar 30, 2022